Bromelain: Pineapple-Derived Enzyme for Inflammation and Sinusitis

← Back to articles

What bromelain is and how it works

Bromelain is a crude pineapple extract containing several closely related cysteine proteases plus a handful of non-protein components. In laboratory and animal models it shows antiedematous, anti-inflammatory, antithrombotic, and fibrinolytic activity (Maurer 2001). Notably, a portion of orally ingested bromelain appears to survive digestion and remain enzymatically active after absorption — unusual for an orally dosed protein, and part of why systemic effects are plausible at all. The same review noted that several of its actions, including its effects on immune signaling and tissue invasion, do not depend purely on proteolytic activity, implying that non-protein cofactors in the extract also matter. Mechanistically, bromelain is thought to reduce several pro-inflammatory mediators (including bradykinin and certain prostaglandins), modulate fibrin breakdown, and exert a mild anti-platelet effect.

Sinusitis evidence

The sinusitis literature is where bromelain has its longest history of use, though the evidence is thinner than the European reputation implies. A systematic review of herbal medicines for rhinosinusitis identified three randomized trials of bromelain (two in acute sinusitis, one in mixed acute/chronic patients), all of which reported some positive findings; a meta-analysis of the two acute-sinusitis trials concluded that adjunctive bromelain significantly improves some symptoms of acute rhinosinusitis (Guo 2006). The reviewers were explicit that the overall quality of the herbal-medicine evidence was limited (median methodological quality 3 of 5) and that bromelain should be regarded as a possibly effective adjunct rather than a standalone treatment. Bromelain remains available over the counter in many European pharmacies for this purpose, typically as an add-on to standard care over roughly a week.

Post-surgical swelling and pain

The most consistent modern data come from oral surgery, specifically the removal of impacted third molars (wisdom teeth). A systematic review and meta-analysis of six randomized trials found that bromelain produced a large improvement in quality-of-life measures during the first postoperative week — physical appearance, social isolation, and sleep quality — and a moderate reduction in pain intensity at both 24 hours and 7 days, but found no convincing evidence that it reduced facial swelling or trismus (jaw stiffness) (Mendes 2019). A subsequent placebo-controlled three-arm trial reported that both purified bromelain and a titrated pineapple extract significantly cut postoperative pain and the need for ibuprofen compared with placebo (Colletti 2024). So the dental-surgery signal for pain and recovery comfort is fairly robust; the older blanket claim that bromelain reliably reduces post-operative oedema is not well supported by the pooled data.

Osteoarthritis and joint pain

Bromelain has been studied as a gentler alternative to NSAIDs for knee osteoarthritis, with genuinely mixed results. A review of the early clinical studies concluded that the available (largely uncontrolled or comparative) trials suggested potential benefit but were not adequate to establish efficacy or optimal dose (Brien 2004). An open dose-ranging study in adults with mild acute knee pain found dose-dependent symptom improvement (Walker 2002) — but open studies without a placebo arm are prone to large apparent effects. The better-controlled trials are sobering: a double-blind randomized comparison of an oral enzyme-rutoside combination (containing bromelain and trypsin) against diclofenac found the enzyme preparation non-inferior to the NSAID over six weeks (Akhtar 2004), and a single-blind pilot study found bromelain comparable to diclofenac at 4 weeks, with further improvement out to 16 weeks (Kasemsuk 2016). The recurring caveat across this literature is that placebo-controlled trials are scarce, the active-controlled trials cannot rule out that both arms simply regressed to the mean, and the trials are small.

Safety and practical use

For a systemic anti-inflammatory effect, bromelain is taken between meals on an empty stomach; taken with food it acts mainly as a digestive enzyme. Doses in the inflammatory trials vary widely, commonly in the range of a few hundred milligrams two to three times daily (potency is often expressed in GDU or FIP units rather than milligrams, which makes cross-product comparison difficult). Tolerability is generally good. The notable risks follow from its biology: a mild anti-platelet and fibrinolytic effect means caution is warranted with anticoagulants (warfarin, direct oral anticoagulants), antiplatelet drugs, and in the perioperative window — stopping bromelain one to two weeks before elective surgery is prudent. Allergic reactions can occur in people sensitized to pineapple or with latex-fruit cross-reactivity, and mild gastrointestinal upset is the most common minor complaint. Because bromelain can enhance the absorption of some antibiotics, anyone combining it with prescription medication should check with a clinician or pharmacist first.

Sources

1. Maurer HR. "Bromelain: biochemistry, pharmacology and medical use." Cellular and Molecular Life Sciences, 2001;58(9):1234–1245. PMID 11577981. DOI: 10.1007/PL00000936.
2. Guo R, Canter PH, Ernst E. "Herbal medicines for the treatment of rhinosinusitis: a systematic review." Otolaryngology — Head and Neck Surgery, 2006;135(4):496–506. PMID 17011407. DOI: 10.1016/j.otohns.2006.06.1254.
3. Mendes MLT, do Nascimento-Júnior EM, Reinheimer DM, Martins-Filho PRS. "Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical trials." Medicina Oral, Patología Oral y Cirugía Bucal, 2019;24(1):e61–e69. PMID 30573710. DOI: 10.4317/medoral.22731.
4. Colletti A, Procchio C, Pisano M, Martelli A, Pellizzato M, Cravotto G. "An Evaluation of the Effects of Pineapple-Extract and Bromelain-Based Treatment after Mandibular Third Molar Surgery: A Randomized Three-Arm Clinical Study." Nutrients, 2024;16(6):784. PMID 38542694. DOI: 10.3390/nu16060784.
5. Brien S, Lewith G, Walker A, Hicks SM, Middleton D. "Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies." Evidence-Based Complementary and Alternative Medicine, 2004;1(3):251–257. PMID 15841258. DOI: 10.1093/ecam/neh035.
6. Akhtar NM, Naseer R, Farooqi AZ, Aziz W, Nazir M. "Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee — a double-blind prospective randomized study." Clinical Rheumatology, 2004;23(5):410–415. PMID 15278753. DOI: 10.1007/s10067-004-0902-y.
7. Kasemsuk T, Saengpetch N, Sibmooh N, Unchern S. "Improved WOMAC score following 16-week treatment with bromelain for knee osteoarthritis." Clinical Rheumatology, 2016;35(10):2531–2540. PMID 27470088. DOI: 10.1007/s10067-016-3363-1.
8. Walker AF, Bundy R, Hicks SM, Middleton RW. "Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults." Phytomedicine, 2002;9(8):681–686. PMID 12587686. DOI: 10.1078/094471102321621269.